MedPath

NuMe Health

NuMe Health logo
🇺🇸United States
Ownership
Private
Established
2009-01-01
Employees
1
Market Cap
-
Website
http://www.numehealth.com

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Early Phase 1:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Early Phase 1
1 (50.0%)
Not Applicable
1 (50.0%)

Pilot Study of the Effect of MN-504 Cobiotic Formulation on the Efficacy and Tolerability of Metformin

Early Phase 1
Completed
Conditions
Type 2 Diabetes
First Posted Date
2013-05-31
Last Posted Date
2014-07-24
Lead Sponsor
NuMe Health
Target Recruit Count
10
Registration Number
NCT01866462
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

A Pilot Study to Determine the Effect of a Cobiotic Formulation on the Gastrointestinal Microbiome

Not Applicable
Completed
Conditions
Pre Diabetic
Interventions
Drug: Placebo
First Posted Date
2012-11-12
Last Posted Date
2014-07-24
Lead Sponsor
NuMe Health
Target Recruit Count
45
Registration Number
NCT01724736
Locations
🇺🇸

Pennington Biomedical Research Center, Baton Rouge, Louisiana, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.